and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Epizyme Stock Price (Quote) NASDAQ:EPZM
$1.48 ( 0% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.49 | $1.58 | Tuesday, 5th Jul 2022 EPZM stock ended at $1.48. During the day the stock fluctuated 1.36% from a day low at $1.47 to a day high of $1.49. |
| 90 days | $0.41 | $1.58 | |
| 52 weeks | $0.41 | $7.94 |
Historical Epizyme prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $1.47 | $1.49 | $1.47 | $1.48 | 3 740 613 |
| 2022-07-01 | $1.48 | $1.48 | $1.47 | $1.48 | 2 516 521 |
| 2022-06-30 | $1.46 | $1.48 | $1.46 | $1.47 | 4 509 802 |
| 2022-06-29 | $1.47 | $1.50 | $1.46 | $1.47 | 12 863 950 |
| 2022-06-28 | $1.46 | $1.48 | $1.46 | $1.48 | 10 557 636 |
| 2022-06-27 | $1.57 | $1.58 | $1.46 | $1.48 | 41 893 443 |
| 2022-06-24 | $0.97 | $0.98 | $0.86 | $0.95 | 17 684 735 |
| 2022-06-23 | $0.89 | $0.96 | $0.83 | $0.96 | 2 065 880 |
| 2022-06-22 | $0.85 | $0.90 | $0.80 | $0.86 | 2 263 498 |
| 2022-06-21 | $0.75 | $0.84 | $0.71 | $0.79 | 2 415 491 |
| 2022-06-17 | $0.63 | $0.74 | $0.63 | $0.69 | 3 403 879 |
| 2022-06-16 | $0.65 | $0.67 | $0.61 | $0.65 | 1 595 651 |
| 2022-06-15 | $0.66 | $0.70 | $0.61 | $0.68 | 2 203 276 |
| 2022-06-14 | $0.67 | $0.68 | $0.63 | $0.65 | 2 145 462 |
| 2022-06-13 | $0.57 | $0.70 | $0.56 | $0.67 | 2 247 709 |
| 2022-06-10 | $0.64 | $0.64 | $0.58 | $0.61 | 3 404 378 |
| 2022-06-09 | $0.71 | $0.72 | $0.62 | $0.65 | 3 056 412 |
| 2022-06-08 | $0.61 | $0.73 | $0.60 | $0.71 | 4 830 414 |
| 2022-06-07 | $0.55 | $0.66 | $0.52 | $0.62 | 4 702 815 |
| 2022-06-06 | $0.52 | $0.56 | $0.49 | $0.54 | 4 049 082 |
| 2022-06-03 | $0.45 | $0.53 | $0.45 | $0.52 | 2 369 778 |
| 2022-06-02 | $0.42 | $0.48 | $0.42 | $0.46 | 4 133 209 |
| 2022-06-01 | $0.44 | $0.44 | $0.41 | $0.42 | 3 071 272 |
| 2022-05-31 | $0.46 | $0.47 | $0.42 | $0.42 | 3 537 240 |
| 2022-05-27 | $0.45 | $0.47 | $0.42 | $0.45 | 1 418 418 |
| 2022-05-26 | $0.48 | $0.50 | $0.43 | $0.44 | 1 857 175 |
| 2022-05-25 | $0.45 | $0.51 | $0.43 | $0.48 | 1 228 665 |
| 2022-05-24 | $0.48 | $0.48 | $0.44 | $0.45 | 1 360 224 |
| 2022-05-23 | $0.51 | $0.57 | $0.47 | $0.48 | 1 530 034 |
| 2022-05-20 | $0.52 | $0.54 | $0.46 | $0.51 | 962 410 |
| 2022-05-19 | $0.53 | $0.55 | $0.50 | $0.53 | 1 648 332 |
| 2022-05-18 | $0.57 | $0.60 | $0.52 | $0.54 | 2 317 287 |
| 2022-05-17 | $0.52 | $0.57 | $0.50 | $0.56 | 1 171 518 |
| 2022-05-16 | $0.55 | $0.56 | $0.48 | $0.50 | 1 656 206 |
| 2022-05-13 | $0.54 | $0.58 | $0.50 | $0.52 | 4 651 217 |
| 2022-05-12 | $0.44 | $0.59 | $0.44 | $0.54 | 2 136 257 |
| 2022-05-11 | $0.58 | $0.64 | $0.46 | $0.47 | 1 973 938 |
| 2022-05-10 | $0.59 | $0.65 | $0.57 | $0.59 | 1 477 901 |
| 2022-05-09 | $0.67 | $0.69 | $0.59 | $0.62 | 2 475 092 |
| 2022-05-06 | $0.67 | $0.68 | $0.63 | $0.66 | 1 849 519 |
| 2022-05-05 | $0.70 | $0.72 | $0.65 | $0.67 | 1 027 662 |
| 2022-05-04 | $0.68 | $0.74 | $0.63 | $0.73 | 1 577 325 |
| 2022-05-03 | $0.67 | $0.69 | $0.62 | $0.67 | 1 279 236 |
| 2022-05-02 | $0.67 | $0.71 | $0.65 | $0.69 | 1 653 811 |
| 2022-04-29 | $0.65 | $0.71 | $0.64 | $0.65 | 735 425 |
| 2022-04-28 | $0.68 | $0.69 | $0.63 | $0.67 | 1 013 068 |
| 2022-04-27 | $0.71 | $0.73 | $0.67 | $0.68 | 2 506 431 |
| 2022-04-26 | $0.77 | $0.78 | $0.70 | $0.71 | 1 158 351 |
| 2022-04-25 | $0.70 | $0.78 | $0.70 | $0.77 | 1 543 009 |
| 2022-04-22 | $0.78 | $0.79 | $0.67 | $0.71 | 323 605 |
Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. The companys proprietary product platform creates small molecule inhibitors of enzymes known as histone methyltransferases (HMTs). Its lead product candidate includes tazemetostat, an inhibitor of the EZH2 HMT, which is in Phase II clinical study in adults with relapsed or refractory non-Hodgkin lymphoma; and in phase II s... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
